Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gunwant Mallik

Neurological Surgery Powell, OH Medical Doctor

NPI 1376527663 CMS profile 243131

25 Hidden Ravines Dr, Powell, OH 43065

Open in the dashboard

General payments

$56,862

105 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gunwant Mallik of Powell, OH is reported in the CMS Open Payments database as having received $56,862 across 105 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,421 13
2024 General $6,951 18
2023 General $3,470 5
2022 General $13,901 17
2021 General $4,119 22
2020 General $9,550 11
2019 General $17,449 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gunwant Mallik
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Gunwant Mallik were reported at $1,421. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Gunwant Mallik Neurological Surgery median Middle half National median
2019 $17,449 $582 $138–$3,006 $163
2020 $9,550 $294 $76–$2,174 $114
2021 $4,119 $387 $105–$2,432 $132
2022 $13,901 $542 $139–$2,989 $149
2023 $3,470 $534 $145–$2,697 $160
2024 $6,951 $574 $155–$3,046 $164
2025 $1,421 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Centinel Spine, LLC $24,283 16 payments
  2. NuVasive, Inc. $18,609 19 payments
  3. Cerapedics, Inc. $5,992 31 payments
  4. Alphatec Spine, Inc $3,751 6 payments
  5. Globus Medical, Inc. $2,756 8 payments
  6. Boston Scientific Corporation $443 9 payments
  7. Medtronic, Inc. $408 5 payments
  8. Medtronic USA, Inc. $247 3 payments
  9. icotec Medical Inc. $112 1 payment
  10. Arteriocyte Medical Systems, Inc. $103 2 payments
  11. Other $158 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $25,250 6 payments
  2. Royalty or License $21,340 26 payments
  3. Travel and Lodging $5,996 8 payments
  4. Food and Beverage $3,547 51 payments
  5. Honoraria $500 1 payment
  6. Education $229 13 payments
Products named General payments · program years 2019–2025
  1. Affix Spine/Spine Surgery $13,946 19 payments
  2. MIDLINE II-Ti $9,309 3 payments
  3. Affix Spine/Spine Surgery $7,394 7 payments
  4. PRODISC C $6,041 3 payments
  5. I-FACTOR PEPTIDE ENHANCED BONE GRAFT Peptide Enhanced Bone Graft $5,992 31 payments
  6. STALIF M $5,143 2 payments
  7. Other - Miscellaneous $3,539 3 payments
  8. MIDLINE II $3,505 2 payments
  9. I-FACTOR PEPTIDE ENHANCED BONE GRAFT Peptide Enhanced Bone Graft $634 14 payments
  10. I-FACTOR PEPTIDE ENHANCED BONE GRAFT Peptide Enhanced Bone Graft $634 14 payments
  11. Other $2,154 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

254

Median for Neurosurgery: 83

Drug cost

$2,143

Median for Neurosurgery: $872

Branded share of claims

15%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 76 $612
Pregabalin Generic 21 $554
Duloxetine Hcl Generic 17 $357
Tramadol Hcl Generic 55 $185
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 27 $160
Cephalexin Generic 19 $143
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 11 $91
Meloxicam Generic 28 $42

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$26,640

Medicare's payments for the services billed

Medicare patients

96

Average age 75

Services billed

164

55 women, 41 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 40%
Ischemic heart disease 34%
Diabetes 32%
Chronic kidney disease 25%
Atrial fibrillation 22%
Heart failure 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

105 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record